diaceutics
1 known investors
Find your way into diaceutics
Sign up to see every warm intro you have to diaceutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the diaceutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Diaceutics operates DXRX, a diagnostic commercialization platform that integrates real-world lab, genomic, clinical, claims, and social-determinants data to help pharma and biotech companies commercialize precision-medicine therapies. Its tools identify testing behaviors and engage physicians to close the gap between diagnostic testing and treatment adoption.
Investors · 1
Frequently asked questions
- What does diaceutics do?
- Diaceutics operates DXRX, a diagnostic commercialization platform that integrates real-world lab, genomic, clinical, claims, and social-determinants data to help pharma and biotech companies commercialize precision-medicine therapies. Its tools identify testing behaviors and engage physicians to close the gap between diagnostic testing and treatment adoption.
- Who are diaceutics's investors?
- diaceutics's investors include Clarendon Fund Managers Ltd..
